GB201916210D0 - High purity tryptamines and methods of synthesis thereof - Google Patents

High purity tryptamines and methods of synthesis thereof

Info

Publication number
GB201916210D0
GB201916210D0 GBGB1916210.6A GB201916210A GB201916210D0 GB 201916210 D0 GB201916210 D0 GB 201916210D0 GB 201916210 A GB201916210 A GB 201916210A GB 201916210 D0 GB201916210 D0 GB 201916210D0
Authority
GB
United Kingdom
Prior art keywords
tryptamines
synthesis
methods
high purity
purity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1916210.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Priority to GBGB1916210.6A priority Critical patent/GB201916210D0/en
Publication of GB201916210D0 publication Critical patent/GB201916210D0/en
Priority to JP2022526074A priority patent/JP7423131B2/en
Priority to BR112022008919A priority patent/BR112022008919A2/en
Priority to CN202080087091.0A priority patent/CN114829340B/en
Priority to CA3160337A priority patent/CA3160337C/en
Priority to NZ788543A priority patent/NZ788543A/en
Priority to IL292753A priority patent/IL292753B2/en
Priority to EP20816376.6A priority patent/EP3844147B1/en
Priority to KR1020237033500A priority patent/KR20230142817A/en
Priority to PL20816375.8T priority patent/PL3873883T3/en
Priority to EP20816375.8A priority patent/EP3873883B1/en
Priority to AU2020378647A priority patent/AU2020378647B2/en
Priority to HRP20230281TT priority patent/HRP20230281T1/en
Priority to PCT/EP2020/081502 priority patent/WO2021089872A1/en
Priority to PCT/EP2020/081503 priority patent/WO2021089873A1/en
Priority to HUE20816376A priority patent/HUE059403T2/en
Priority to ES20816375T priority patent/ES2940811T3/en
Priority to HUE20816375A priority patent/HUE061482T2/en
Priority to DK20816376.6T priority patent/DK3844147T3/en
Priority to KR1020227018623A priority patent/KR20220082092A/en
Priority to CA3160334A priority patent/CA3160334C/en
Priority to CN202080087092.5A priority patent/CN114829341B/en
Priority to PT208163758T priority patent/PT3873883T/en
Priority to PT208163766T priority patent/PT3844147T/en
Priority to HRP20220797TT priority patent/HRP20220797T1/en
Priority to AU2020381103A priority patent/AU2020381103B2/en
Priority to MX2022005399A priority patent/MX2022005399A/en
Priority to JP2022526073A priority patent/JP7422473B2/en
Priority to PL20816376.6T priority patent/PL3844147T3/en
Priority to ES20816376T priority patent/ES2920681T3/en
Priority to EP22214748.0A priority patent/EP4180037A1/en
Priority to US17/412,828 priority patent/US11643390B2/en
Priority to IL292754A priority patent/IL292754A/en
Priority to US17/662,261 priority patent/US11578039B2/en
Priority to US18/152,465 priority patent/US20230167056A1/en
Priority to US18/193,866 priority patent/US20230250059A1/en
Priority to JP2023202672A priority patent/JP2024028798A/en
Priority to US18/602,171 priority patent/US20240217929A1/en
Ceased legal-status Critical Current

Links

GBGB1916210.6A 2019-11-07 2019-11-07 High purity tryptamines and methods of synthesis thereof Ceased GB201916210D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GBGB1916210.6A GB201916210D0 (en) 2019-11-07 2019-11-07 High purity tryptamines and methods of synthesis thereof
BR112022008919A BR112022008919A2 (en) 2019-11-07 2020-11-09 COMPOUND AND METHOD FOR TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS
DK20816376.6T DK3844147T3 (en) 2019-11-07 2020-11-09 CONNECTIONS
CA3160334A CA3160334C (en) 2019-11-07 2020-11-09 Compounds
CN202080087091.0A CN114829340B (en) 2019-11-07 2020-11-09 Compounds of formula (I)
CA3160337A CA3160337C (en) 2019-11-07 2020-11-09 Method of synthesis
NZ788543A NZ788543A (en) 2019-11-07 2020-11-09 Dimethyltryptamine derivatives and their use in psychedelic-assisted psychotherapy
IL292753A IL292753B2 (en) 2019-11-07 2020-11-09 Compounds, compositions comprising same, and uses thereof in the treatment of psychiatric or neurological disorders
EP20816376.6A EP3844147B1 (en) 2019-11-07 2020-11-09 Compounds
KR1020237033500A KR20230142817A (en) 2019-11-07 2020-11-09 Compounds
KR1020227018623A KR20220082092A (en) 2019-11-07 2020-11-09 compound
EP20816375.8A EP3873883B1 (en) 2019-11-07 2020-11-09 Method of synthesis
AU2020378647A AU2020378647B2 (en) 2019-11-07 2020-11-09 Method of synthesis
HRP20230281TT HRP20230281T1 (en) 2019-11-07 2020-11-09 Method of synthesis
PCT/EP2020/081502 WO2021089872A1 (en) 2019-11-07 2020-11-09 Compounds
PCT/EP2020/081503 WO2021089873A1 (en) 2019-11-07 2020-11-09 Method of synthesis
HUE20816376A HUE059403T2 (en) 2019-11-07 2020-11-09 Compounds
ES20816375T ES2940811T3 (en) 2019-11-07 2020-11-09 Synthesis method
HUE20816375A HUE061482T2 (en) 2019-11-07 2020-11-09 Method of synthesis
JP2022526074A JP7423131B2 (en) 2019-11-07 2020-11-09 Compound
PL20816375.8T PL3873883T3 (en) 2019-11-07 2020-11-09 Method of synthesis
EP22214748.0A EP4180037A1 (en) 2019-11-07 2020-11-09 Method of synthesis
MX2022005399A MX2022005399A (en) 2019-11-07 2020-11-09 Compounds.
PT208163758T PT3873883T (en) 2019-11-07 2020-11-09 Method of synthesis
PT208163766T PT3844147T (en) 2019-11-07 2020-11-09 Compounds
HRP20220797TT HRP20220797T1 (en) 2019-11-07 2020-11-09 Compounds
AU2020381103A AU2020381103B2 (en) 2019-11-07 2020-11-09 Compounds
CN202080087092.5A CN114829341B (en) 2019-11-07 2020-11-09 Synthesis method
JP2022526073A JP7422473B2 (en) 2019-11-07 2020-11-09 Synthesis method
PL20816376.6T PL3844147T3 (en) 2019-11-07 2020-11-09 Compounds
ES20816376T ES2920681T3 (en) 2019-11-07 2020-11-09 compounds
US17/412,828 US11643390B2 (en) 2019-11-07 2021-08-26 Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses
IL292754A IL292754A (en) 2019-11-07 2022-05-03 Method of synthesis
US17/662,261 US11578039B2 (en) 2019-11-07 2022-05-06 Compounds
US18/152,465 US20230167056A1 (en) 2019-11-07 2023-01-10 Compounds
US18/193,866 US20230250059A1 (en) 2019-11-07 2023-03-31 Synthesis of n,n-dimethyltryptamine-type compounds, methods, and uses
JP2023202672A JP2024028798A (en) 2019-11-07 2023-11-30 Compound
US18/602,171 US20240217929A1 (en) 2019-11-07 2024-03-12 Synthesis of n,n-dimethyltryptamine-type compounds, methods, and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1916210.6A GB201916210D0 (en) 2019-11-07 2019-11-07 High purity tryptamines and methods of synthesis thereof

Publications (1)

Publication Number Publication Date
GB201916210D0 true GB201916210D0 (en) 2019-12-25

Family

ID=69062301

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1916210.6A Ceased GB201916210D0 (en) 2019-11-07 2019-11-07 High purity tryptamines and methods of synthesis thereof

Country Status (1)

Country Link
GB (1) GB201916210D0 (en)

Similar Documents

Publication Publication Date Title
IL292754A (en) Method of synthesis
GB201804005D0 (en) New polymorph and new path to synthesize tafamidis
IL271938A (en) Method for the preparation of synthesis gas
IL271939A (en) Method for the preparation of synthesis gas
EP3515880A4 (en) Methods and compositions for synthesis of encoded libraries
MX2019011468A (en) Synthesis of mcl-1 inhibitor.
IL271941A (en) Method for the preparation of synthesis gas
IL305751A (en) Synthesis of omecamtiv mecarbil
ZA202101837B (en) Method for the preparation of synthesis gas
GB201916210D0 (en) High purity tryptamines and methods of synthesis thereof
EP3749638A4 (en) Synthesis of 4-chlorokynurenines and intermediates
PL3498665T3 (en) Method for the production of synthesis gas
GB201903055D0 (en) Method of oligonucleaotide synthesis
PL3720813T3 (en) System and process for production of synthesis gas
ZA201900717B (en) Synthesis of (s)-2-amino-4-methyl-1-((r)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
GB202118156D0 (en) Methods of synthesis
GB202118099D0 (en) Methods of synthesis
GB202118005D0 (en) Methods of synthesis
GB201917499D0 (en) Methods of synthesis
GB201902495D0 (en) Methods of synthesis and intermediates
IL282566A (en) Synthesis of (s)-6-hydroxytryptophan and derivatives thereof
ZA202001140B (en) Derivatives of luciferin and methods for their synthesis
GB201807468D0 (en) Methods of synthesis
IL311128A (en) Synthesis of nirogacestat
GB201820685D0 (en) Synthesis of 8-chloroadenosine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)